ADARx Pharmaceuticals, Inc. SEC filings

Filings

1. SCHEDULE 13GADARx Pharmaceuticals, Inc.ADRX2d

   ADARx Pharmaceuticals, Inc. (ADRX) reports major shareholder

   • LAV Biosciences Fund V, L.P. and others beneficially own 11.1% of ADRX shares.
   • As of September 30, 2026, total shares owned: 11,858,655.
   • Dr. Shi is managing partner of multiple funds with voting power.

   LAV Biosciences Fund V, L.P., filed by

2. SCHEDULE 13DADARx Pharmaceuticals, Inc.ADRXOct 5

   ADRX: SR One Capital files 13D

   • SR One Capital Management, LLC owns 9.3% of ADRX
   • SR One Fund I Aggregator holds 5,554,094 shares
   • SR One Opportunities Fund I holds 1,953,505 shares

   SR ONE CAPITAL MANAGEMENT, LLC

3. SCHEDULE 13DADARx Pharmaceuticals, Inc.ADRXOct 2

   ADARx Pharmaceuticals, Inc. (ADRX) - OrbiMed files 13D

   • OrbiMed Advisors LLC owns 14,913,764 shares (14%)
   • OrbiMed Capital GP VII LLC owns 14,325,529 shares (13.4%)
   • OrbiMed Advisors Israel II Ltd owns 9,292,025 shares (8.7%)

   ORBIMED ADVISORS LLC

4. SCHEDULE 13GADARx Pharmaceuticals, Inc.ADRXOct 1

   Ownership stake disclosure

   BCLS Fund III Investments, LP

5. 4ADARx Pharmaceuticals, Inc.ADRXSep 30

   3 insider filings

   Erez Chimovits, insider filing for ADRX

   Show all 3

   • 4Insider filing for ADRXSep 30
   • 4Insider filing for ADRXSep 30
   • 4Insider filing for ADRXSep 30

   Erez Chimovits, reporting

6. 4ADARx Pharmaceuticals, Inc.ADRXSep 29

   3 insider filings

   SR ONE CAPITAL MANAGEMENT, LLC, insider filing for ADRX

   Show all 3

   • 4Insider filing for ADRXSep 29
   • 4Insider filing for ADRXSep 29
   • 4Insider filing for ADRXSep 29

   SR ONE CAPITAL MANAGEMENT, LLC, reporting

7. S-8ADARx Pharmaceuticals, Inc.ADRXSep 28

   Employee stock plan registration

8. 4ADARx Pharmaceuticals, Inc.ADRXSep 28

   5 insider filings

   Robert William Ackles, insider filing for ADRX

   Show all 5

   • 4Insider filing for ADRXSep 28
   • 4Insider filing for ADRXSep 28
   • 4Insider filing for ADRXSep 28
   • 4Insider filing for ADRXSep 28
   • 4Insider filing for ADRXSep 28

   Robert William Ackles, reporting

9. 8-KADARx Pharmaceuticals, Inc.ADRXSep 28

   Current report

10. 424B4ADARx Pharmaceuticals, Inc.ADRXSep 28

    Securities offering

11. EFFECTADARx Pharmaceuticals, Inc.ADRXSep 25

    Registration declared effective

12. 3ADARx Pharmaceuticals, Inc.ADRXSep 24

    13 insider filings

    SR ONE CAPITAL MANAGEMENT, LLC, new insider at ADRX

    Show all 13

    • 3New insider at ADRXSep 24
    • 3New insider at ADRXSep 24
    • 3New insider at ADRXSep 24
    • 3New insider at ADRXSep 24
    • 3New insider at ADRXSep 24
    • 3New insider at ADRXSep 24
    • 3New insider at ADRXSep 24
    • 3New insider at ADRXSep 24
    • 3New insider at ADRXSep 24
    • 3New insider at ADRXSep 24
    • 3New insider at ADRXSep 24
    • 3New insider at ADRXSep 24
    • 3New insider at ADRXSep 24

    SR ONE CAPITAL MANAGEMENT, LLC, reporting

13. S-1MEFADARx Pharmaceuticals, Inc.ADRXSep 24

    S-1MEF filing

14. CERTADARx Pharmaceuticals, Inc.ADRXSep 24

    CERT filing

15. 8-A12BADARx Pharmaceuticals, Inc.Sep 22

    8-A12B filing

16. S-1/AADARx Pharmaceuticals, Inc.Sep 21

    Securities offering (amended)

17. S-1/AADARx Pharmaceuticals, Inc.Sep 14

    Securities offering (amended)

18. S-1ADARx Pharmaceuticals, Inc.Sep 4

    Securities offering

Older filings on EDGAR